Danaher (DHR)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Danaher | DHR | Healthcare | Diagnostics & Research | 84 | 3.0% |
| Current Price (12/01) | $319.72 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 28,065.0 | |||
| Sales Growth Forecast | 7.1% | |||
| Net Profit Margin | 22.9% | |||
| Projected Shares Outstanding | 700.00 | |||
| EPS - Five year Forecast | $12.95 | |||
| Average P/E Ratio | 28.0 | |||
| Projected Average Price | $362.56 | |||
| Price Appreciation (Annualized) | 2.5% | |||
| Annual Dividend Yield | 0.5% | |||
| Projected Annual Return | 3.0% | |||
| Quality | ||||
| Financial Strength | 94 | 23.5 | ||
| EPS Stability | 75 | 18.7 | ||
| Industry Sales Growth Rate | 9.0% | 9.9 | ||
| Industry Net Profit Margin | 18.0% | 15.9 | ||
| Calculated Quality Rating | 67.9 | |||
| Fool CAPS | ||||
Total Players
596
Outperforms
24
Underperforms
All-Stars (116)
112
Outperforms (97%)
4
Underperforms
|
||||
| Fundamental Data Updated: 10/08/2021 | ||||